BLOG INFORMATION
Enterprise
Industry
Media

08

2024-08

For solid tumors, the world's first CD99 CAR-T cell therapy product is approved by CDE clinical.

For solid tumors, the world's first CD99 CAR-T cell therapy product is approved by CDE clinical.

2024-08-08

For solid tumors, the world's first CD99 CAR-T cell therapy product is approved by CDE clinical.

08

2024-08

[Information] | Hubei Radio and Television: Ten Years of Grinding a Sword CAR-T Anticancer Drugs Produced in Hubei to Be Listed

[Information] | Hubei Radio and Television: Ten Years of Grinding a Sword CAR-T Anticancer Drugs Produced in Hubei to Be Listed

2024-08-08

[Information] | Hubei Radio and Television: Ten Years of Grinding a Sword CAR-T Anticancer Drugs Produced in Hubei to Be Listed

03

2023-03

Industry Information | CDE Releases Technical Guidelines for Pharmaceutical Research and Evaluation of Oncolytic Virus Products (Trial)

Industry Information | CDE Releases Technical Guidelines for Pharmaceutical Research and Evaluation of Oncolytic Virus Products (Trial)

2023-03-03

Industry Information | CDE Releases Technical Guidelines for Pharmaceutical Research and Evaluation of Oncolytic Virus Products (Trial)

29

2022-08

About the publicity of the project "technology and application of CAR-T cell immunotherapy for hematological tumors"

Our company's "Technology and Application of CAR-T Cell Immunotherapy for Hematological Tumors" project plans to apply for the Hubei Provincial Science and Technology Progress Award. According to the requirements of the notice of the provincial science and technology department on the nomination of the 2022 provincial science and technology award, the project is publicized. (See Annex for details of publicity)

2022-08-29

About the publicity of the project "technology and application of CAR-T cell immunotherapy for hematological tumors"
< 1 >
Wuhan Bo Rui Da Biotechnology Co., Ltd.

Contact Us

86-027-59318269

Official E-mail: cart@bio-raid.com

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

WeChat Public Number

Official WeChat

Company address: Floor 4 and Floor 5 (1) of Building 3, Phase 3.1, Wuhan Optics Valley International Biomedical Enterprise Accelerator, 388 Gaoxin 2nd Road, Donghu New Technology Development Zone, Wuhan City

Copyright©2012-2024 Bio-Raid All Rights Reserved Wuhan Porida Biotechnology Co., Ltd. Copyright No. 42018502002564, An Bei, E Public Network

Powered by www.300.cn

Terms of Service

Privacy Policy